MYC and colorectal carcinoma: Kalra et al. [129] have shown that EVs released by CRC cells and containing the mutant β-catenin and high Wnt/β-catenin activity boost the expression of target genes as c-myc and cyclin D1 when transferred to recipient cells (Table 3).